Stock Market News

Lilly to buy gene-editing partner Verve for up to $1.3 billion in cardiac care push

Jun 17, 2025 - 13:26
 0
Lilly to buy gene-editing partner Verve for up to $1.3 billion in cardiac care push
Read More

Tags:

Previous Article

FTSE 100 today: shares drop amid escalating Middle East tensions; oil stocks gain

Next Article

Costco fans share key hack to solve major member problem

Related Posts

Mizuho lifts price targets for AI server stocks

May 19, 2025  0

Xpeng develops advanced chips for Volkswagen vehicles - report

Xpeng develops advanced chips for Volkswagen vehicles -...

Jun 12, 2025  0

FTSE 100 today:opens higher amid earnings; Greggs surges, Vodafone unveils buyback

FTSE 100 today:opens higher amid earnings; Greggs surge...

May 20, 2025  0